Regulation of CD40 ligand expression in systemic lupus erythematosus

Current Opinion in Rheumatology

Volumn 13, Issue 5, 2001, Pages 361-369

  Crow, Mary K ^a,b   Kirou, Kyriakos A ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 39; IMMUNOGLOBULIN RECEPTOR; TUMOR NECROSIS FACTOR;

B LYMPHOCYTE; CELL ACTIVATION; CELL SURFACE; DENDRITIC CELL; DRUG TARGETING; HELPER CELL; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TARGET CELL; TRANSCRIPTION REGULATION;

ANIMALS; ANTIGENS, CD40; CD4-POSITIVE T-LYMPHOCYTES; CD40 LIGAND; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICE; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, HELPER-INDUCER;

EID: 0034810412     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200109000-00004     Document Type: Review

References (102)

1. Identification of a novel surface protein on activated CD4+ T cells that induces contact-dependent B cell differentiation (help)
2. Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles. Roles of T cell-B cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help
3. Activated human T cells express a ligand for the human B cell-associated antigen CD40 which participates in T cell-dependent activation of B lymphocytes
4. Recombinant human CD40 ligand stimulates B cell proliferation and immunoglobulin E secretion
5. A novel ligand on activated T helper cells binds CD40 and transduces the signal for the cognate activation of B cells
6. The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: Expression of a soluble form of gp39 with B cell stimulatory activity
7. Molecular and biological characterization of a murine ligand for CD40
8. Immune regulation by CD40 and its ligand gp39
9. In vivo CD40-gp39 interactions are essential for thymus-dependent immunity. II. Prolonged in vivo suppression of primary and secondary humoral immune responses by an antibody targeted to the CD40 ligand, gp39
10. Cutting edge: CD40 ligand is a limiting factor in the humoral response to T cell-dependent antigens
11. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway
12. Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand
13. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion
14. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation
15. IL-12 reverses the suppressive effect of the CD40 ligand blockade on experimental autoimmune encephalomyelitis (EAE)
16. The roles of CD28 and CD40 ligand in T cell activation and tolerance
17. Functional interactions of T cells with endothelial cells: The role of CD40L-CD40-mediated signals
18. CD40 on human endothelial cells: Inducibility by cytokines and functional regulation of adhesion molecule expression
19. Expression of functional CD40 by vascular endothelial cells
20. CD40 ligation induces tissue factor expression in human vascular smooth muscle cells
21. Microglial activation resulting from CD40-CD40L interaction after β-amyloid stimulation
22. CD40 ligand (CD154) triggers a short-term CD4+ T cell activation response that results in secretion of immunomodulatory cytokines and apoptosis
23. Therapeutic activity of agonistic monoclonal antibodies against CD40 in a chronic autoimmune inflammatory process
24. Increased T cell autoreactivity in the absence of CD40-CD40 ligand interactions: A role of CD40 in regulatory T cell development
25. The CD40 ligand expressed by human B cells costimulates B cell responses
26. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells
27. Regulation of CD40 and CD40 ligand by the AT-hook transcription factor AKNA
28. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells
29. Mechanisms of T-helper cell activation and function in systemic lupus erythematosus
30. Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis
31. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: Phenotype and possible role in autoreactivity
32. Increased expression of CD40 ligand on systemic lupus erythematosus lymphocytes
33. Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production
34. Peripheral blood lymphocytes in SLE-hyperexpression of CD154 on T and B lymphocytes and increased number of double negative T cells
35. CD40 ligand expressed on B cells in the BXSB mouse model of systemic lupus erythematosus
36. Antibody production in autoimmune BXSB mice. I. CD40L-expressing B cells need fewer signals for polyclonal antibody synthesis
37. The soluble form of CD40 ligand is present in systemic lupus erythematosus sera and correlates with disease activity
38. The soluble CD40 ligand sCD154 in systemic lupus erythematosus
39. Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides
40. Possible role for CD40-CD40L in the regulation of interstitial infiltration in the kidney
41. Requirement for CD154 in the progression of atherosclerosis
42. Thymus dysfunction and chronic inflammatory disease in gp39 transgenic mice
43. Lymphoid abnormalities in CD40 ligand transgenic mice suggest tight regulation in gene therapy approaches to hyper immunoglobulin M (IgM) syndrome
44. CD40 and CD154 in cell-mediated immunity
45. Functional CD40 ligand is expressed by T cells in rheumatoid arthritis
46. Expression and function of CD40 in rheumatoid arthritis synovium
47. Expression of interleukin-1 2 in synovial tissue from patients with rheumatoid arthritis
48. The role of CD8+ CD40L+ T cells in the formation of germinal centers in rheumatoid synovitis
49. Ligation of CD40 induced tumor necrosis factor-alpha in rheumatoid arthritis: A novel mechanism of activation of synoviocytes
50. Increased expression of CD40 ligand (CD154) on CD4+ T cells as a marker of disease activity in rheumatoid arthritis
51. Human rheumatoid factor production is dependent on CD40 signaling and autoantigen
52. The role of CD40 ligand and tumor necrosis factor alpha signaling in the transgenic K/BxN mouse model of rheumatoid arthritis
53. Increased CD40 expression on muscle cells of polymyositis and dermatomyositis: Role of CD40-CD40 ligand interaction in IL-6, IL-15, and monocyte chemoattractant protein-1 production
54. CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis
55. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis
56. Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis
57. CD40/CD40 ligand interactions are critical for elicitation of autoimmune-mediated fibrosis in the lung
58. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells
59. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71)
60. A humanized therapeutic CD4 mAb inhibits TOR-induced IL-2, IL-4 and IL-10 secretion and expression of CD25, CD40L and CD69
61. Ligation of B7 with CD28/CTLA4 on T cells results in CD40 ligand expression, interleukin-4 secretion and efficient help for antibody production by B cells
62. Human endothelial cells augment early CD40 ligand expression in activated CD4+ T cells through LFA-3-mediated stabilization of mRNA
63. ICOS is critical for CD40-mediated antibody class switching
64. ICOS is essential for effective T-helper-cell responses
65. CD40 ligand is expressed and functional on activated neonatal T cells
66. IL-12 up-regulates CD40 ligand (CD154) expression on human T cells
67. Human Th1 responses driven by IL-12 are associated with enhanced expression of CD40 ligand
68. IL-2 and IL-15 regulate CD154 expression on activated CD4 T cells
69. Cutting edge: Stromal cell-derived factor-1 is a costimulator for CD4+ T cell activation
70. Lysophosphatidylcholine upregulates CD40 ligand expression in newly activated human T cells
71. Osteopontin augments CD3-mediated interferon-gamma and CD40 ligand expression by T cells, which results in IL-12 production from peripheral blood mononuclear cells
72. Cyclosporin A inhibits CD40 ligand expression in T lymphocytes
73. Increase of intracellular calcium is the essential signal for the expression of CD40 ligand
74. 2+/calmodulin kinase type IV/Gr and calcineurin
75. Requirement of a second signal via protein kinase C or protein kinase A for maximal expression of CD40 ligand. Involvement of transcriptional and posttranscriptional mechanisms
76. Regulation of CD40L expression by cyclic AMP: Contrasting proinflammatory and inhibitory actions
77. Differential effects of cyclosporine A, methyprednisolone, mycophenolate, and rapamycin on CD154 induction and requirement for NFκB: Implications for tolerance induction
78. The human gp39 promoter. Two distinct nuclear factors of activated T cell protein-binding elements contribute independently to transcriptional activation
79. The CD40L promoter contains nuclear factor of activated T cell-binding motifs which require AP-1 binding for activation of transcription
80. Transcriptional activity of the distal CD40 ligand promoter
81. Identification of a CD28 response element in the CD40 ligand promoter
82. Regulation of CD154 (CD40 ligand) mRNA stability during T cell activation
83. Characterization of RNA binding proteins associated with CD40 ligand (CD154) mRNA turnover in human T lymphocytes
84. Identification of a complex that binds to the CD154 3′ untranslated region: Implications for a role in message stability during T cell activation
85. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism
86. Nucleolin and YB-1 are required for JNK-mediated interleukin-2 mRNA stabilization during T cell activation
87. Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability
88. CD154 polymorphism in Spanish populations: Differences in the allelic distribution between Canary Islanders and Peninsulars
89. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40
90. Impaired lymphokine secretion in anergic CD4+ T cells leads to defective help for B cell growth and differentiation
91. Regulatory defects in cbl and mitogen-activated protein kinase (extracellular signal-related kinase) pathways cause persistent hyperexpression of CD40 ligand in human lupus T cells
92. Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice. Response correlates with the absence of an anti-antibody response
93. Long-term inhibition of murine lupus by brief simultaneous blockade of the B7/CD28 and CD40/gp39 costimulation pathways
94. Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: Preservation of kidney function
95. Inhibition of the CD40-CD40 ligand pathway prevents murine membranous glomerulonephritis
96. Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40
97. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis
98. Reduction of atherosclerosis in mice by inhibition of CD40 signalling
99. Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates
100. Phase I clinical trial of a monoclonal antibody against CD40-ligand (IDEC-131) in patients with systemic lupus erythematosus
101. Thromboembolic complications after treatment with monoclonal antibody against CD40 ligand
102. Trichostatin A reverses skewed expression of CD154, interleukin-10, and interferon-γ gene and protein expression in lupus T cells